Diagnosis and therapy of ulcerative colitis: Pouchitis;Diagnostik und theraoie der colitis ulcerosa: Pouchitis

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 9, 2004, Pages 1021-1024

  Stange, E F ^a   Buhr, H J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; METRONIDAZOLE; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADENOCARCINOMA; COLITIS; COLORECTAL SURGERY; CONFERENCE PAPER; GASTROINTESTINAL ENDOSCOPY; HISTOLOGY; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; INTESTINE CARCINOMA; MALABSORPTION; PROCTOCOLECTOMY; ULCERATIVE COLITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR;

ANTI-BACTERIAL AGENTS; COLITIS, ULCERATIVE; CONTROLLED CLINICAL TRIALS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; HUMANS; POUCHITIS; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RISK FACTORS;

EID: 10344260724     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813513     Document Type: Conference Paper

References (65)

1. Buhr HJ, Heuschen UA, Stern J et al. Kontinenz-erhaltende Operation nach Proktokolektomie. Indikationen, Technik und Ergebnisse. Chirurg 1993; 64: 601-613 (III)
2. Kartheuser AH, Parc R, Penna CP et al. Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience. Surgery 1996; 119: 615-623 (III)
3. Stahlberg D, Gullberg K, Liljeqvist L et al. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996; 39: 1012-1018 (IIa)
4. Meagher AP, Farouk R, Dozois RR et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998; 85: 800-803 (III)
5. Hurst RD, Chung TP, Rubin M et al. The implications of acute pouchitis on the long-term functional results after restorative proctocolectomy. Inflamm Bowel Dis 1998; 4: 280-284 (III)
6. Tiainen J, Matikainen M. Long-term clinical outcome and anemia after restorative proctocolectomy for ulcerative colitis. Scand J Gastroenterol 2000; 35: 1170-1173 (III)
7. Tiainen J, Matikainen M. Health-related quality of life after ileal J-pouch-anal anastomosis for ulcerative colitis: long-term results. Scand J Gastroenterol 1999; 34: 601-605 (III)
8. Seidel SA, Peach SE, Newman M et al. Ileoanal pouch procedures: clinical outcomes and quality-of-life assessment. Am Surg 1999; 65: 40-46 (III)
9. Tiainen J, Matikainen M, Aitola P et al. Histological and macroscopic changes in the pelvic pouch: long-term follow up after restorative proctocolectomy for ulcerative colitis (UC). Colorectal Dis 2001; 3: 28-32 (III)
10. Heuschen UA, Autschbach F, Allemeyer EH et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum 2001; 44: 487-499 (IIb)
11. Cheifetz A, Itzkowitz S. The diagnosis and treatment of pouchitis in inflammatory bowel disease. J Clin Gastroenterol 2004; 38: 44-50 (IV)
12. Mahadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology 2003; 124: 1636-1650 (IV)
13. Hurst RD, Molinari M, Chung TP et al. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131: 497-500; discussion 501-502
14. Lohmuller JL, Pemberton JH, Dozois RR et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouchanal anastomosis. Ann Surg 1990; 211: 622-627; discussion 627-629 (III)
15. Nicholls RJ, Banerjee AK. Pouchitis: risk factors, etiology, and treatment. World J Surg 1998; 22: 347-351 (IV)
16. Penna C, Dozois R, Tremaine W et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234-239 (IIb)
17. Fleshner PR, Vasiliauskas EA, Kam LY et al. High level perinuclear anti-neutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001; 49: 671-677 (IIb)
18. Yasuda N, Thomas P, Ellis H et al. Perinuclear anti-neutrophil cytoplasmic antibodies in ulcerative colitis after restorative proctocolectomy do not correlate with the presence of pouchitis. Scand J Gastroenterol 1998; 33: 509-513 (III)
19. Shanahan F. Neutrophil autoantibodies in inflammatory bowel disease: are they important? Gastroenterology 1994; 107: 586-589 (IV)
20. Esteve M, Mallolas J, Klaassen J et al. Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis. Gut 1996; 38: 894-898 (III)
21. Reumaux D, Colombel JF, Masy E et al. Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in ulcerative colitis (UC): no relationship with disease activity. Inflamm Bowel Dis 2000; 6: 270-274 (IIb)
22. Schmidt CM, Lazenby AJ, Hendrickson RJ et al. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998; 227: 654-662 (III)
23. Gustavsson S, Weiland I.H, Kelly KA. Relationship of backwash ileitis to ileal pouchitis after ileal pouch-anal anastomosis. Dis Colon Rectum 1987; 30: 25-28 (III)
24. Thoeni RF, Fell SC, Engelstad B et al. Ileoanal pouches: comparison of CT, scintigraphy, and contrast enemas for diagnosing postsurgical complications. Am J Roentgenol 1990; 154: 73-78 (III)
25. Libicher M, Scharf J, Wunsch A et al. MRI of pouch-related fistulas in ulcerative colitis after restorative proctocolectomy. J Comput Assist Tomogr 1998; 22: 664-668 (III)
26. Hrung JM, Levine MS, Rombeau JL et al. Total proctocolectomy and ileoanal pouch: the role of contrast studies for evaluating postoperative leaks. Abdom Imaging 1998; 23: 375-379 (III)
27. Solomon MJ, McLeod RS, O'Connor BI et al. Assessment of peripouch inflammation after ileoanal anastomosis using endoluminal ultrasonography. Dis Colon Rectum 1995; 38: 182-187 (III)
28. Sandborn WJ, Tremaine WJ, Batts KP et al. Pouchitis after ileal pouchanal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994; 69: 409-415 (III)
29. Shen B, Achkar JP, Lashner BA et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121: 261-267 (IIb)
30. Kuisma J, Nuutinen H, Luukkonen P et al. Long term metabolic consequences of ileal pouch-anal anastomosis for ulcerative colitis. Am J Gastroenterol 2001; 96: 3110-3116 (III)
31. Sarigol S, Wyllie R, Gramlich T et al. Incidence of dysplasia in pelvic pouches in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis. J Pediatr Gastroenterol Nutr 1999; 28: 429-434 (III)
32. Veress B, Reinholt FP, Lindquist K et al. Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients. Gastroenterology 1995; 109: 1090-1097 (III)
33. Stallmach A, Moser C, Hero-Gross R et al. Pattern of mucosal adaptation in acute and chronic pouchitis. Dis Colon Rectum 1999; 42: 1311-1317 (III)
34. Shepherd NA, Healey CJ, Warren BF et al. Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut 1993; 34: 101-105 (III)
35. Setti Carraro P, Talbot IC, Nicholls RJ. Longterm appraisal of the histological appearances of the ileal reservoir mucosa after restorative proctocolectomy for ulcerative colitis. Gut 1994; 35: 1721-1727 (III)
36. Setti Carraro PG, Talbot IC, Nicholls JR. Patterns of distribution of endoscopic and histological changes in the ileal reservoir after restorative proctocolectomy for ulcerative colitis. A long-term follow-up study. Int J Colorectal Dis 1998; 13: 103-107 (III)
37. Gullberg K, Stahlberg D, Liljeqvist L et al. Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology 1997; 112: 1487-1492 (III)
38. Fruin AB, El-Zammer O, Stucchi AF et al. Colonic metaplasia in the ileal pouch is associated with inflammation and is not the result of long-term adaptation. J Gastrointest Surg 2003; 7: 246-253 (IIb)
39. Stahlberg D, Veress B, Tribukait B et al. Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study. Dis Colon Rectum 2003; 46: 770-778 (III)
40. Thompson-Fawcett MW, Marcus V, Redston M et al. Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis. Gastroenterology 2001; 121: 275-281 (IIb)
41. Shen B, Achkar JP, Lashner BA et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002; 97: 972-977 (IIb)
42. Sandborn WJ, McLeod R, Jewell DP. Medical therapy for induction and maintenance of remission in pouchitis: a systematic review. Inflamm Bowel Dis 1999; 5: 33-39 (Ia)
43. Gionchetti P, Rizzello F, Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-309 (Ib)
44. Svaninger G, Nordgren S, Oresland T et al. Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch. Scand J Gastroenterol 1993; 28: 695-700 (III)
45. Rauh SM, Schoetz DJ Jr, Roberts PL et al. Pouchitis - is it a wastebasket diagnosis? Dis Colon Rectum 1991; 34: 685-689 (III)
46. Shen B, Achkar JP, Lashner BA et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001; 7: 301-305 (Ib)
47. Nygaard K, Bergan T, Bjorneklett A et al. Topical metronidazole treatment in pouchitis. Scand J Gastroenterol 1994; 29: 462-467 (III)
48. Gionchetti P, Rizzello F, Helwig U et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-1209 (Ib)
49. Madden MV, McIntyre AS, Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994; 39: 1193-1196 (Ib)
50. Mimura T, Rizzello F, Helwig U et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002; 16: 909-917 (III)
51. Gionchetti P, Rizzello F, Venturi A et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713-718 (III)
52. Wischmeyer P, Pemberton JH, Phillips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993; 68: 978-981 (Ib)
53. Shepherd NA, Hulten L, Tytgat GN et al. Pouchitis. Int J Colorectal Dis 1989; 4: 205-229 (IV)
54. Tytgat GN, van Deventer SJ. Pouchitis. Int J Colorectal Dis 1988; 3: 226-228 (IV)
55. MacMillan F, Warner A. Efficacy of immunosuppressive therapy for the treatment of chronic pouchitis following ileal pouch-anal anastomosis. Am J Gastroenterol 1999; 94: 2677 (IV)
56. Rowley S, Candinas D, Mayer AD et al. Restorative proctocolectomy and pouch anal anastomosis for ulcerative colitis following orthotopic liver transplantation. Gut 1995; 37: 845-847 (III)
57. Zins BJ, Sandborn WJ, Penna CR et al. Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosis. Am J Gastroenterol 1995; 90: 2177-2181 (III)
58. Kuisma J, Luukkonen P, Jarvinen H et al. Risk of osteopenia after proctocolectomy and ileal pouch-anal anastomosis for ulcerative colitis. Scand J Gastroenterol 2002; 37: 171-176 (IIb)
59. Heuschen UA, Heuschen G, Autschbach F et al. Adenocarcinoma in the ileal pouch: late risk of cancer after restorative proctocolectomy. Int J Colorectal Dis 2001; 16: 126-130 (IV)
60. lwama T, Kamikawa J, Higuchi T et al. Development of invasive adenocarcinoma in a long-standing diverted ileal J-pouch for ulcerative colitis: report of a case. Dis Colon Rectum 2000; 43: 101-104 (IV)
61. Hassan C, Zullo A, Speziale G et al. Adenocarcinoma of the ileoanal pouch anastomosis: an emerging complication? Int J Colorectal Dis 2003; 18: 276-278 (IV)
62. Hyman N. Rectal cancer as a complication of stapled IPAA. Inflamm Bowel Dis 2002; 8: 43-45 (IV)
63. Puthu D, Rajan N, Rao R et al. Carcinoma of the rectal pouch following restorative proctocolectomy. Report of a case. Dis Colon Rectum 1992; 35: 257-260 (IV)
64. Stern H, Walfisch S, Mullen B et al. Cancer in an ileoanal reservoir: a new late complication? Gut 1990; 31: 473-475 (IV)
65. Gullberg K, Lindforss U, Zetterquist H et al. Cancer risk assessment in long-standing pouchitis. DNA aberrations are rare in transformed neoplastic pelvic pouch mucosa. Int J Colorectal Dis 2002; 17: 92-97 (IV)